The Canadian government is planning to change the way prices are set for new patented drugs and cut the maximum prices at which these drugs can be sold by up to 70%. But this reform could prove very costly for patients. If it goes forward and fails to take into account the adverse effects of reference pricing systems, which have been well documented by various international bodies, Canadians could see their access to new drugs slowed down or even compromised.

The defects and impediments inherent in a top-down bureaucratic health care system like Canada‘s.

The debate over the nationalization of drug insurance.

The role of the Commissaire à la santé et au bien-être.

Health professionals should be able to use all their skills.

Health professionals should be able to use all their skills.

Quebec’s Health Minister recently announced that she wanted specialized nurse practitioners (SNPs) to be able to make diagnoses, as is the case everywhere else in Canada. The Collège des médecins du Québec (CMQ) ended up making peace with the idea, while the Fédération des médecins omnipraticiens du Québec (FMOQ) is still not on board, claiming that this act must be reserved to physicians. Is this resistance justified?

Access to the health system and its cost.

Access to drug insurance in Quebec.

Patients who do not show up for their medical appointment.